# Adma Biologics, Inc.: Form SC 13D, filed Feb 4, 2022

- Company: [Adma Biologics, Inc.](/companies/adma.md) (CIK 1368514)
- Form: SC 13D
- Filed: 2022-02-04
- Accepted by EDGAR: Feb 4, 2022, 08:30 ET
- Period: not reported
- Accession: 0000902664-22-001112
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1368514/000090266422001112/p22-0735sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1368514/000090266422001112/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1368514/000090266422001112/p22-0735sc13d.htm

Filed Feb 4, 2022.
Source: SEC EDGAR, the filing index for accession 0000902664-22-001112. Last ingested by Listed: Nov 10, 2026, 16:34 ET. No prices; not investment advice.
